These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5417222)

  • 41. [Characteristic of the distribution of neurotropic agents in the brain (review of the literature)].
    Fateev VA; Titov NS
    Farmakol Toksikol; 1981; 44(5):630-3. PubMed ID: 6118291
    [No Abstract]   [Full Text] [Related]  

  • 42. Biliary excretion and enterohepatic recirculation of methaqualone in the rat.
    Polk A; Delong AF; Smyth RD; Herczeg T; Burns BJ; Klunk LJ; Reavey-Cantwell NH
    Drug Metab Dispos; 1974; 2(4):365-9. PubMed ID: 4153284
    [No Abstract]   [Full Text] [Related]  

  • 43. Biochemical studies of drug and steroid metabolism by the liver.
    Estabrook RW; Remmer H; Hildebrandt A; Cooper DY
    Masui; 1968 Sep; 17(10):990-7. PubMed ID: 5750969
    [No Abstract]   [Full Text] [Related]  

  • 44. [On 3 cases of attempted suicide with 2-methyl-3-o-tolyl-4-quinozolone].
    Gianasi GC
    Acta Anaesthesiol; 1966; 17(1):111-20. PubMed ID: 5952757
    [No Abstract]   [Full Text] [Related]  

  • 45. Isolation and identification of hypnotics. 9. Simultaneous identification of hypnotics and alcohols.
    Kondo M
    Nihon Hoigaku Zasshi; 1972 Jan; 26(1):24-30. PubMed ID: 5064054
    [No Abstract]   [Full Text] [Related]  

  • 46. [Transplacental transfer of methyl-o-tolyl-quinazolinone in rat and its fetal repercussions].
    Perretti F; Zilletti L
    Riv Ostet Ginecol; 1969 Jan; 24(1):1-11. PubMed ID: 5404735
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study on metabolism of alpha, alpha-diethyl-3,4-methylenedioxyphenylacetamide (Hoe 264) in guinea pigs].
    Volz M
    Arzneimittelforschung; 1973 Aug; 23(8):1024-7. PubMed ID: 4801019
    [No Abstract]   [Full Text] [Related]  

  • 48. Gas chromatographic determination of hypnotics in biological materials combined with purification procedure using gel filtration.
    Maeba Y
    J Forensic Sci; 1970 Jan; 15(1):92-109. PubMed ID: 5419865
    [No Abstract]   [Full Text] [Related]  

  • 49. [Medico-legal studies on isolation and identification of hypnotics by thin layer chromatography (TLC). 1. Thin layer chromatography of hypnotics and tranquilizers].
    Masuda T
    Kumamoto Igakkai Zasshi; 1972 Feb; 46(2):105-18. PubMed ID: 4402986
    [No Abstract]   [Full Text] [Related]  

  • 50. The detection of sedative-hypnotic drugs in the impaired driver.
    White JM; Graves MH
    J Chromatogr Sci; 1974 May; 12(5):219-24. PubMed ID: 4833005
    [No Abstract]   [Full Text] [Related]  

  • 51. The identification of non-barbiturate hypnotics from biological specimens.
    Cravey RH; Jain NC
    J Chromatogr Sci; 1974 May; 12(5):237-45. PubMed ID: 4151274
    [No Abstract]   [Full Text] [Related]  

  • 52. Metabolism of detomidine in the rat. II. Characterisation of metabolites in urine.
    Salonen JS; Vuorilehto L; Eloranta M; Karjalainen A
    Eur J Drug Metab Pharmacokinet; 1988; 13(1):59-65. PubMed ID: 3396615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection, assay and rate of excretion of mecloqualone in animals and man.
    Dubnk B; Towne CA; Bush MT
    Toxicol Appl Pharmacol; 1969 Nov; 15(3):632-41. PubMed ID: 5353825
    [No Abstract]   [Full Text] [Related]  

  • 54. [Studies on the fate of 3-methyl-4-phenyl-3,4-dihydroxy-1-butyne in rats].
    Wahl D; Wick H
    Arzneimittelforschung; 1967 Feb; 17(2):235-40. PubMed ID: 5631489
    [No Abstract]   [Full Text] [Related]  

  • 55. Mass screening and confirmation of methaqualone and its metabolites in urine by radioimmunoassay-thin-layer chromatography.
    Budd RD; Yang FC; Leung WJ
    J Chromatogr; 1980 Mar; 190(1):129-32. PubMed ID: 7380944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis and biochemistry of aza analogues of methaqualone. Part 7: biotransformation of 2-methyl-3-(2'-methylphenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidine (Kr 100) (author's transl)].
    Bornschein I; Kraft R; Pfeifer S; Ullmann M; Langner H
    Pharmazie; 1979 Nov; 34(11):732-5. PubMed ID: 545343
    [No Abstract]   [Full Text] [Related]  

  • 57. [ELECTROENCEPHALOGRAPHIC STUDY ON METHAQUALONE].
    MIYAGISHI K
    Nihon Yakurigaku Zasshi; 1964 Nov; 60():569-72. PubMed ID: 14280382
    [No Abstract]   [Full Text] [Related]  

  • 58. Methaqualone pharmacokinetics after single- and multiple-dose administration in man.
    Nayak RK; Smyth RD; Chamberlain JH; Polk A; DeLong AF; Herczeg T; Chemburkar PB; Joslin RS; Reavey-Cantwell NH
    J Pharmacokinet Biopharm; 1974 Apr; 2(2):107-21. PubMed ID: 4427217
    [No Abstract]   [Full Text] [Related]  

  • 59. Detection of methaqualone and its metabolites in urine.
    Burnett D; Goudie JH; Sherriff JM
    J Clin Pathol; 1969 Sep; 22(5):602-4. PubMed ID: 5364446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164).
    Saito C; Sakai S; Yukawa Y; Yamamoto H; Takagi H
    Arzneimittelforschung; 1969 Dec; 19(12):1945-9. PubMed ID: 4985336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.